Understanding resistant hypertension.
| Autor: | Bachinsky A; At the time this article was written, Alexandra Bachinsky, Erin Leah Jones , and Tiffany Thompson were students in the PA program at the University of Lynchburg in Lynchburg, Va. Sondra DePalma practices at PinnacleHealth CardioVascular Institute in Harrisburg, Pa., is an adjunct assistant professor at A.T. Still University in Mesa, Ariz., and is director of regulatory and professional practice for the American Academy of PAs in Alexandria, Va. Joyce Nicholas is director of evaluation, assessment, and compliance and a professor in the PA program at the University of Lynchburg. Eric Schmidt is an assistant professor in the PA program at the University of Lynchburg. The authors have disclosed no potential conflicts of interest, financial or otherwise., Jones EL, Thompson T, DePalma S, Nicholas J, Schmidt E |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | JAAPA : official journal of the American Academy of Physician Assistants [JAAPA] 2021 Dec 01; Vol. 34 (12), pp. 15-20. |
| DOI: | 10.1097/01.JAA.0000800232.29507.22 |
| Abstrakt: | Abstract: Resistant hypertension affects about 17% of the US population. However, it is difficult to diagnose because of multiple factors that influence adequate treatment of BP, including patient lifestyle and comorbidities, improper therapeutic regimens, and secondary mechanisms. Possible causes of resistant hypertension include nonmodulator hypertension, which affects patients who have an inappropriate response to elevated sodium through the renin-angiotensin-aldosterone system. Early identification and frequent follow-up can help patients achieve BP goals more rapidly and may reduce morbidity and mortality associated with complications of hypertension, including cerebrovascular accident, cardiovascular disease, and kidney disease. (Copyright © 2021 American Academy of Physician Assistants.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|